Whipplewood Advisors, LLC Neurocrine Biosciences Inc Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 45 shares of NBIX stock, worth $6,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$6,858% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
639Shares Held
94.1MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.52 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$785 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$392 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$284 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...